This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Muthiah (Mano) Manoharan, PhD
Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc.

Profile

Dr. Muthiah (Mano) Manoharan serves as a Senior Vice President and a Distinguished Research Scientist at Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA. Dr. Manoharan joined Alnylam in 2003. He built the chemistry group at Alnylam and pioneered the discovery and development of RNA interference-based human therapeutics. Dr. Manoharan has had a distinguished career as a world-leading chemist in the areas of oligonucleotide chemical modifications, conjugation chemistry, and delivery platforms (lipid nanoparticles, polymer conjugates, and complex-forming strategies). He is an author of more than 200 publications (nearly 37,000 citations with an h-index of 85 and an i10-index of 329) and over 400 abstracts, as well as the inventor of over 225 issued U.S. patents.

Agenda Sessions

  • Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Bringing RNAi Therapeutics to Patients Around the World

    2:45pm
  • Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Discovery and Development of Semaglutide – The First Orally Available GLP-1 Peptide for Treatment of Type 2 Diabetes

    10:15am
  • Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Oligonucleotide Therapeutics: Past, Present and Future

    10:15am
  • Panel Discussion Moderator and Panelists

    3:45pm
  • SESSION NAME: Targeted Delivery of Oligonucleotides - SESSION CHAIR & SPEAKERS BELOW

    On Demand
  • SESSION NAME: Targeted Delivery of Oligonucleotides - SESSION CHAIR & SPEAKERS BELOW

    On Demand